A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United ...

A research team from Kumamoto University has made a new discovery that reveals how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their finding potentially lays the ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure. But a landmark ...

Around 10 million people globally live with the life-threatening human T-cell lymphotropic virus type-1 (HTLV-1), yet it remains a poorly understood disease that currently has no preventative ...

While HIV makes global headlines, its lesser-known “lost cousin” virus HTLV-1 affects about 20 million people worldwide, causing blood cancers with survival rates less than two years. It also triggers ...

This study shows that TGF-β triggers the nuclear translocation of HBZ specifically in ATL cells from patients with ATL, not in HTLV-1–infected cells from asymptomatic carriers. JunB interacts with HBZ ...

A team of researchers found a potential new target for treating diseases associated with human T-cell leukemia virus type 1, including a specific type of leukemia and a neuroinflammatory disease ...